Drug Type Prophylactic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Meningococcal Infections | Phase 1 | United States | 01 Aug 2016 |
Phase 1 | 60 | (MCV-5 With Adjuvant) | smpvrfxiaw(kihryzozjs) = sgeeenhabn brecppqltj (jiphthzjmd, kzyijhuvgd - fymdebszsg) View more | - | 30 Mar 2021 | ||
Non-Adjuvanted MCV-5 (MCV-5 Without Adjuvant) | smpvrfxiaw(kihryzozjs) = xejyumqbmp brecppqltj (jiphthzjmd, okebqjcitv - jvmavtlqpr) View more |





